In this issue:
IL-10 autoantibodies and HLA-DRB1* 01:03 in IBD
Serum proteomics in paediatric IBD
CV events with immunomodulators, biologics and 5-ASA in elderly IBD
Induction and maintenance mirikizumab in Chinese patients with UC
Tofacitinib, filgotinib or upadacitinib for UC
Ravagalimab for moderate-to-severe UC
Predicting response to iron therapy in active IBD
1-year effectiveness of upadacitinib in perianal CD
Including diagnostic pelvic MRI for early detection of paediatric perianal CD
Associations of demographic, clinical and dietary factors with IBD flare
Please login below to download this issue (PDF)